Radiobiology - Molecular Profiles of Particular Cancer and Relationship to Therapy
In this course, we provide an overview of biomarker definitions and potential use in the management of cancer patients. We then describe the historical evolution of efforts by NRG Oncology to develop and validate tissue-based molecular biomarkers to direct management of GU cancers treated with radiation. Topical examples will be provided the punctuate these efforts to realize the goal of precision radiation medicine.
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, participants should be able to do the following:
- Describe the different types of biomarkers and how they impact treatment of cancer patients.
- Identify molecular biomarkers that are in development and those that are available as standard of care to help guide management of GU cancer patients treated with radiation therapy.
Phuoc Tran, MD, PhD, is employed by the University of Maryland and receives compensation from AstraZeneca, Johnson & Johnson, RefleXion Medical Inc., and Natsar Pharm.
All relevant relationships have been mitigated.All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 0.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 Certificate of AttendanceThis activity was designated for 0.50 AMA PRA Category 1 Credit™.